World Library  
Flag as Inappropriate
Email this Article




Classification and external resources


DiseasesDB = 22575
ICD-10 N92.0
ICD-9-CM 627.0
eMedicine med/1449
MeSH D008595

Menorrhagia or hematomunia is an abnormally heavy and prolonged menstrual period at irregular intervals. Menorrhagia can be caused by abnormal blood clotting, disruption of normal hormonal regulation of periods, or disorders of the endometrial lining of the uterus. Depending upon the cause, it may be associated with abnormally painful periods (dysmenorrhea). Fibroids can cause menorrhagia.


  • Signs and symptoms 1
  • Causes 2
    • Disorders of coagulation 2.1
    • Excessive build-up in endometrial lining 2.2
    • Consideration by nature of the menstrual cycle 2.3
    • Differential diagnosis 2.4
    • ICD-9 codes 2.5
  • Diagnosis 3
  • Treatment 4
    • Medications 4.1
    • Surgery 4.2
  • Complications 5
  • Footnotes 6
  • General references 7

Signs and symptoms

A normal menstrual cycle is 21–35 days in duration, with bleeding lasting an average of 5 days and total blood flow between 25 and 80 mL. A blood loss of greater than 80 mL or lasting longer than 7 days constitutes menorrhagia (also called hypermenorrhea). Some authors use menorrhagia exclusively when describing excessive quantity and hypermenorrhea for prolonged duration (although most use both terms interchangeably in the clinical setting). In practice this is not usually directly measured by patients or doctors. Menorrhagia also occurs at predictable and normal (usually about 28 days) intervals, distinguishing it from menometrorrhagia, which occurs at irregular and more frequent intervals. It is possible to estimate the amount of bleeding by the number of tampons or pads a woman uses during her period. As a guide a light tampon will hold 6 mL of blood, a regular tampon will hold 6 to 9 mL of blood, a super tampon will hold 9 to 12 mL of blood, a super plus tampon will hold 12 to 15 mL of blood and an ultra tampon will hold 15 to 18 mL of blood. One may also have lighter cycles in volume, but blood flow may continue more than seven days thus constituting menorrhagia.


Usually no causative abnormality can be identified and treatment is directed at the symptom, rather than a specific mechanism. Most common causes include blood disorder or stress-related disorders. A brief overview of causes is given below, followed by a more formal medical list based on the nature of the menstrual cycle experienced.

Disorders of coagulation

With the shedding of an endometrial linings blood vessels, normal coagulation process must occur to limit and eventually stop the blood flow. Blood disorders of platelets (such as ITP) or coagulation (such as von Willebrand disease) or use of anticoagulant medication (such as warfarin) are therefore possible causes, although a rare minority of cases. Platelet function studies pfa col/epi can also be used to ascertain platelet function abnormalities

Excessive build-up in endometrial lining

Periods soon after the onset of menstruation in girls (the menarche) and just before menopause may in some women be particularly heavy. Hormonal disorders involving the ovaries-pituitary-hypothalamus (the ovarian endocrine axis) account for many cases, and hormonal-based treatments may effectively regulate such disorders.

The lining of the uterus builds up naturally under the hormonal effects of pregnancy, and an early spontaneous miscarriage may be mistaken for a heavier than normal period.

As women age and move towards menopause, ovulation is delayed and the remaining follicles in the ovaries become resistant to GnRH (Gonadotropin releasing hormone) secreted by the hypothalamus gland in the brain. Either that or they don't develop an egg, and thus no progesterone is produced. Without progesterone, the estrogen is "unopposed" and keeps building up the lining of the uterus.

During a woman's period, the endometrial lining which is normally shed never gets the signal to stop thickening. It keeps growing and sheds irregularly. Due to the extra thickness, the bleeding is unusually heavy. Less frequently in this age group, too little estrogen causes the irregular bleeding. Most cases of hemorrhagic are due to normal hormonal changes preceding menopause.

Irritation of the endometrium may result in increased blood flow, e.g. from infection (acute or chronic pelvic inflammatory disease) or the contraceptive intrauterine device.

Fibroids in the wall of the uterus sometimes can cause increased menstrual loss if they protrude into the central cavity and thereby increase endometriums surface area.

Abnormalities of the endometrium such as adenomyosis (so called "internal endometriosis") where there is extension into the wall of the uterus gives rise to an enlarged tender uterus. Note, true endometriosis is a cause of pain (dysmenorrhoea) but usually not alteration in menstrual blood loss.

Endometrial carcinoma (cancer of the uterine lining) usually causes irregular bleeding, rather than the cyclical pattern of menorrhagia. Bleeding in between periods (intermenstrual bleeding or IMB) or after the menopause (post-menopausal bleeding or PMB) should always be considered suspicious.

Consideration by nature of the menstrual cycle

Differential diagnosis

  • Pregnancy complications:
  • Nonuterine bleeding:
    • Cervical ectropion/erosion
    • Cervical neoplasia/polyp
    • Cervical or vaginal trauma
    • Condylomata
    • Atrophic vaginitis
    • Foreign bodies
  • Pelvic inflammatory disease (PID):
    • Endometritis
    • Tuberculosis
  • Hypothyroidism
  • Hashimoto's thyroiditis

Menorrhagia (Fibroid)

ICD-9 codes

Classification of some causes
Cause ICD-9 code
Polyp of corpus uteri 621.0
Endometrial cystic hyperplasia 621.3
Other specified disorders of uterus, NEC 621.8
Excessive or frequent menstruation 626.2
Puberty bleeding 626.3
Irregular menstrual cycle 626.4
Metrorrhagia 626.6
Disorders of menstruation and other abnormal bleeding
from female genital tract, other
Premenopausal menorrhagia 627.0
Postmenopausal bleeding 627.1


  • Pelvic and rectal examination
  • Pap smear
  • Pelvic ultrasound scan is the first line diagnostic tool for identifying structural abnormalities.[1]
  • Endometrial biopsy to exclude endometrial cancer or atypical hyperplasia
  • Hysteroscopy


Where an underlying cause can be identified, treatment may be directed at this. Clearly heavy periods at menarche and menopause may settle spontaneously (the menarche being the start and menopause being the cessation of periods).

If the degree of bleeding is mild, all that may be sought by the woman is the reassurance that there is no sinister underlying cause. If anemia occurs then iron tablets may be used to help restore normal hemoglobin levels.

The condition is often treated with hormones, particularly as dysfunctional uterine bleeding commonly occurs in the early and late menstrual years when contraception is also sought. Usually, oral combined contraceptive or progesterone only pills may be taken for a few months, but for longer-term treatment the alternatives of injected Depo Provera or the more recent progesterone releasing IntraUterine System (IUS) may be used. Fibroids may respond to hormonal treatment, and if they do not, then surgical removal may be required.

Tranexamic acid tablets that may reduce loss by up to 50%.[2] This may be combined with hormonal medication previously mentioned.

Anti-inflammatory medication like NSAIDs may also be used. NSAIDs are the first-line medications in ovulatory menorrhagia, resulting in an average reduction of 20-46% in menstrual blood flow. For this purpose, NSAIDs are ingested for only 5 days of the menstrual cycle, limiting their most common adverse effect of dyspepsia.[3]

A definitive treatment for menorrhagia is to perform hysterectomy (removal of the uterus). The risks of the procedure have been reduced with measures to reduce the risk of deep vein thrombosis after surgery, and the switch from the front abdominal to vaginal approach greatly minimizing the discomfort and recuperation time for the patient; however extensive fibroids may make the womb too large for removal by the vaginal approach. Small fibroids may be dealt with by local removal (myomectomy). A further surgical technique is endometrial ablation (destruction) by the use of applied heat (thermoablation).

In the UK the use of hysterectomy for menorrhagia has been almost halved between 1989 and 2003.[4] This has a number of causes: better medical management, endometrial ablation and particularly the introduction of IUS[5][6] which may be inserted in the community and avoid the need for specialist referral; in one study up to 64% of women cancelled surgery.[7]


These have been ranked by the UK's National Institute for Health and Clinical Excellence:[1]



Aside from the social distress of dealing with a prolonged and heavy period, over time the blood loss may prove to be greater than the body iron reserves or the rate of blood replenishment, leading to anemia. Symptoms attributable to the anemia may include shortness of breath, tiredness, weakness, tingling and numbness in fingers and toes, headaches, depression, becoming cold more easily, and poor concentration.


  1. ^ a b "CG44 Heavy menstrual bleeding: Understanding NICE guidance" (PDF).  
  2. ^ Bonnar J, Sheppard BL (September 1996). "Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid". BMJ 313 (7057): 579–82.  
  3. ^ A Shaw, Julia (2014-09-29). "Menorrhagia Treatment & Management".  
  4. ^ Reid P, Mukri F (23 Apr 2005). "Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002-3". BMJ 330 (7497): 938–9.  
  5. ^ Hurskainen R, Teperi J, Rissanen P, Aalto A, Grenman S, Kivelä A, Kujansuu E, Vuorma S, Yliskoski M, Paavonen J (24 Mar 2004). "Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up". JAMA 291 (12): 1456–63.  
  6. ^ Istre O, Trolle B (August 2001). "Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection". Fertil Steril 76 (2): 304–9.  
  7. ^ Stewart A, Cummins C, Gold L, Jordan R, Phillips W (January 2001). "The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review". BJOG 108 (1): 74–86.  

General references

  • Continuous Identification of Research Evidence (collaborative of the WHO, and US CDC & Johns Hopkins Hospital) - Search of Evidence about the IUS
  • Abnormal vaginal bleeding National Guideline Clearinghouse
  • Menorrhagia - Menstrual Abnormalities and Abnormal Uterine Bleeding Menstrual Abnormalities and Abnormal Uterine Bleeding - Armenian Medical Network
  • Abnormal uterine bleeding/dysfunctional uterine bleeding. Intracorp - Public For Profit Organization. 2005. Various pagings. NGC:004390
  • Working group on inherited bleeding disorders rbdd - Rare Bleeding Disorders database
  • Project Red Flag Information About Women and Bleeding Disorders
  • [1] Adenomyosis Information from
  • Working group on menorrhagia Menorrhagia and other gynaecological problems in women affected by bleeding disorders
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.